XOMA Co. (NASDAQ:XOMAO) Sees Significant Increase in Short Interest

XOMA Co. (NASDAQ:XOMAO) was the target of a large increase in short interest during the month of May. As of May 29th, there was short interest totaling 2,149 shares, an increase of 1,468.6% from the May 14th total of 137 shares. Based on an average daily volume of 4,591 shares, the short-interest ratio is presently 0.5 days.

XOMA Trading Up 0.0%

XOMAO traded up $0.01 during trading hours on Tuesday, reaching $25.37. The company’s stock had a trading volume of 890 shares, compared to its average volume of 3,926. XOMA has a fifty-two week low of $24.86 and a fifty-two week high of $26.40. The business’s 50-day moving average is $25.44 and its 200-day moving average is $25.42.

XOMA Company Profile

XOMA Corporation is a clinical-stage biotechnology company specializing in the discovery and development of therapeutic antibodies. The company applies its proprietary protein engineering and antibody optimization platform to generate novel drug candidates targeting autoimmune, inflammatory and metabolic diseases. XOMA’s scientific expertise spans antibody discovery, engineering, in vitro and in vivo testing, and early‐stage clinical development.

In addition to advancing its own pipeline of antibody candidates, XOMA collaborates with pharmaceutical and biotechnology partners to provide research and development services.